Your browser doesn't support javascript.
loading
Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade.
Vitiello, A; La Porta, R; D'Aiuto, V; Ferrara, F.
Affiliation
  • Vitiello A; Clinical Pharmacologist, Pharmaceutical Department, Usl Umbria 1, A.Migliorati Street, 06132 Perugia, Italy.
  • La Porta R; Clinical Pathologist, Pathologist Department, Asur Marche, A.Comandino Street, 61029 Urbino, Italy. Electronic address: raffaele.laporta@sanita.marche.it.
  • D'Aiuto V; Clinical Pathologist, Pathologist Department, Asur Marche, A.Comandino Street, 61029 Urbino, Italy.
  • Ferrara F; Hospital Pharmacist Manager, Pharmaceutical Department, Usl Umbria 1, A.Migliorati Street, 06132 Perugia, Italy. Electronic address: francesco.ferrara@uslumbria1.it.
Hum Immunol ; 82(4): 264-269, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33632561
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C3a / Complement C5a / Complement Activation / Complement Inactivating Agents / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Hum Immunol Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C3a / Complement C5a / Complement Activation / Complement Inactivating Agents / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Hum Immunol Year: 2021 Document type: Article Affiliation country: